The University of Chicago Header Logo

Connection

Philip Charles Hoffman to Receptor, Fibroblast Growth Factor, Type 3

Back to Details
This is a "connection" page, showing publications Philip Charles Hoffman has written about Receptor, Fibroblast Growth Factor, Type 3.
Philip Charles Hoffman
Connection Strength
0.175
Receptor, Fibroblast Growth Factor, Type 3
  1. SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy). J Thorac Oncol. 2019 10; 14(10):1847-1852.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.